Correction in Antifungal prophylaxis for high-risk (immunocompromised)
Correction made for Heart transplant and Lung transplant recipients: both anti-mold AND anti-PJP prophylaxis recommended.
Correction made for Heart transplant and Lung transplant recipients: both anti-mold AND anti-PJP prophylaxis recommended.
The ASP committee updated the COVID guidelines. You will find the following change: -Removal of the pre-exposure prophylaxis guidelines since monoclonal antibodies are no longer easly available. -Clar
To MUHC users: Please note that as of Dec 5, 2022, requests for outpatient antiviral management of COVID-19 for HIGH RISK patients should be directed to the ID-AMB (formerly MicroB/Lachine) service ra
The MUHC ASP committee is happy to announce the update and publication of several guidelines: Pre-exposure prophylaxis to COVID : Recommended Evusheld dose is now increased to 300/300 mg COVID managem